GDRX
GoodRx Holdings, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
+15/100
Last price
3.26
▼ 0.10 (2.98%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
3.38
Prev close
3.36
Day high
3.37
Day low
3.26
Volume
489.25K
Market cap
$1.12B
P/E (TTM)
65.40
52W range
1.77 – 5.81
Day trading desk
Gap from prior close
+0.60%
Prior close 3.36
VWAP
3.30
-1.21% from price
Relative volume
0.33×
Quiet session
Session range
5.52%
3.26 – 3.44
Position in range
0%
Near session low
ATR (14D)
0.10
3.06% of price
Prior day high
3.42
PDH
Prior day low
3.27
PDL
Bid / ask spread
—
Quote not published
Session volume
422.42K
Avg 1.28M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.24%
-0.7%
1M
-6.03%
-7.2%
3M
+10.47%
+6.0%
6M
+59.51%
+41.3%
YTD
+20.66%
+6.4%
1Y
-27.81%
-44.2%
3Y
-41.92%
-124.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on GDRX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+6.09M
Net buying
Buy transactions
23
8.85M shares
Sell transactions
2
2.76M shares
Net transactions
+25
Buys less sells
Sell : buy shares
0.3 : 1
Mixed
Insider-held shares
43.36M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 15, 26 | CHAN THOMAS TC Officer |
— | 2.10K | — | Direct |
| Sep 15, 26 | FENGLER JUSTIN Chief Operating Officer |
— | 3.09K | — | Direct |
| Aug 26, 26 | FRANCISCO PARTNERS IV, L.P. Beneficial Owner of more than 10% of a Class of Security |
SELL | 1.57M | $5.48M | Indirect |
| Aug 21, 26 | FRANCISCO PARTNERS IV, L.P. Beneficial Owner of more than 10% of a Class of Security |
SELL | 1.19M | $4.20M | Indirect |
| Aug 19, 26 | FRANCISCO PARTNERS IV, L.P. Beneficial Owner of more than 10% of a Class of Security |
— | 7.50M | — | Indirect |
| Aug 14, 26 | CHAN THOMAS TC Officer |
— | 10.12K | — | Direct |
| Aug 14, 26 | FENGLER JUSTIN Chief Financial Officer |
— | 48.53K | — | Direct |
| Jul 15, 26 | BARNES WENDY LYNN Chief Executive Officer |
— | 277.29K | — | Direct |
| Jul 15, 26 | CHAN THOMAS TC Officer |
— | 5.79K | — | Direct |
| Jul 15, 26 | MCGINNIS CHRISTOPHER ALAN Chief Financial Officer |
— | 36.99K | — | Direct |
| Jun 16, 26 | REY-GIRAUD AGNES Director |
STOCK | 73.43K | $0 | Direct |
| Jun 16, 26 | WAGNER SCOTT W. Director |
STOCK | 73.43K | $0 | Direct |
| Jun 16, 26 | KENNEDY KELLY J Director |
STOCK | 73.43K | $0 | Direct |
| Jun 16, 26 | BRUEHLMAN RONALD E Director |
STOCK | 73.43K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARNES WENDY LYNN |
Chief Executive Officer | 741.66K | Conversion of Exercise of derivative security |
BEZDEK TREVOR |
Director | 5.61M | Stock Award(Grant) |
BRUEHLMAN RONALD E |
Director | 207.35K | Stock Award(Grant) |
HIRSCH DOUGLAS JOSEPH |
Director | 5.59M | Stock Award(Grant) |
KENNEDY KELLY J |
Director | 207.65K | Stock Award(Grant) |
MCGINNIS CHRISTOPHER ALAN |
Chief Financial Officer | 198.31K | Conversion of Exercise of derivative security |
NABIEY ROMIN |
Officer | 183.06K | Conversion of Exercise of derivative security |
REY-GIRAUD AGNES |
Director | 426.29K | Stock Award(Grant) |
VOERMANN IAN KARSTEN |
Chief Financial Officer | 363.56K | Conversion of Exercise of derivative security |
WAGNER SCOTT W. |
Director | 473.00K | Stock Award(Grant) |
Fundamentals
Market cap$1.12B
Enterprise value$1.36B
Revenue (TTM)$785.23M
Gross profit$713.19M
EBITDA$108.78M
Net income$16.25M
EPS (TTM)$0.05
Free cash flow$112.50M
Total cash$296.11M
Total debt$538.95M
Book value / share$1.90
Shares outstanding107.18M
Float93.97M
Short % of float4.93%
Dividend yield0.00%
Beta (5Y)1.69
Valuation & profitability ratios
Trailing P/E65.40
Forward P/E9.22
PEG ratio—
Price / sales—
Price / book1.72
EV / revenue1.73
EV / EBITDA12.49
Gross margin90.83%
Operating margin11.79%
Profit margin2.07%
Return on equity2.52%
Return on assets3.05%
Debt / equity83.22
Current ratio1.38
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $796.85M | $792.32M | $750.26M | $766.55M | +0.6% |
| Operating revenue | $779.17M | $771.32M | $730.21M | $746.13M | +1.0% |
| Cost of revenue | $57.60M | $48.22M | $66.92M | $65.08M | +19.5% |
| Gross profit | $739.26M | $744.11M | $683.34M | $701.48M | -0.7% |
| Research & development | $121.03M | $123.75M | $135.84M | $143.14M | -2.2% |
| Selling, general & admin | $445.52M | $484.98M | $466.84M | $502.42M | -8.1% |
| Total operating expense | $651.76M | $678.26M | $710.35M | $699.74M | -3.9% |
| Operating income | $87.49M | $65.85M | -$27.01M | $1.74M | +32.9% |
| Net interest income | -$31.67M | -$29.65M | -$24.56M | -$24.97M | -6.8% |
| Pre-tax income | $56.54M | $31.46M | -$55.57M | -$23.23M | +79.7% |
| Tax provision | $26.10M | $15.07M | -$46.70M | $9.60M | +73.2% |
| Net income | $30.44M | $16.39M | -$8.87M | -$32.83M | +85.7% |
| Net income to common | $30.44M | $16.39M | -$8.87M | -$32.83M | +85.7% |
| Basic EPS | 0.09 | 0.04 | -0.02 | -0.08 | +125.0% |
| Diluted EPS | 0.09 | 0.04 | -0.02 | -0.08 | +125.0% |
| EBIT | $99.14M | $84.38M | $1.16M | $11.01M | +17.5% |
| EBITDA | $184.36M | $153.92M | $108.82M | $65.19M | +19.8% |
| Basic shares | 356.33M | 385.74M | 410.31M | 412.86M | -7.6% |
| Diluted shares | 356.97M | 392.17M | 410.31M | 412.86M | -9.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $261.82M | $448.35M | $672.30M | $757.16M | -41.6% |
| Cash & short-term investments | $261.82M | $448.35M | $672.30M | $757.16M | -41.6% |
| Accounts receivable | $235.75M | $145.93M | $143.61M | $117.14M | +61.5% |
| Total current assets | $643.10M | $659.25M | $872.79M | $919.69M | -2.5% |
| Property, plant & equipment | $41.08M | $40.46M | $45.86M | $55.73M | +1.5% |
| Goodwill & intangibles | $633.67M | $587.65M | $567.11M | $602.05M | +7.8% |
| Total assets | $1.40B | $1.39B | $1.59B | $1.60B | +1.2% |
| Total current liabilities | $246.00M | $123.90M | $122.56M | $76.32M | +98.5% |
| Current debt | $5.00M | $5.00M | $8.79M | $7.03M | 0.0% |
| Long-term debt | $483.26M | $486.71M | $647.70M | $651.80M | -0.7% |
| Total debt | $542.81M | $543.39M | $711.07M | $717.02M | -0.1% |
| Total liabilities | $787.80M | $663.41M | $826.84M | $789.80M | +18.7% |
| Retained earnings | -$1.41B | -$1.44B | -$1.46B | -$1.45B | +2.1% |
| Shareholder equity | $616.26M | $724.66M | $761.96M | $814.83M | -15.0% |
| Working capital | $397.10M | $535.35M | $750.23M | $843.37M | -25.8% |
| Net tangible assets | -$17.41M | $137.01M | $194.85M | $212.77M | -112.7% |
| Shares issued | 341.05M | 382.81M | 394.09M | 397.02M | -10.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $30.44M | $16.39M | -$8.87M | -$32.83M | +85.7% |
| Depreciation & amortisation | $85.22M | $69.54M | $107.67M | $54.18M | +22.5% |
| Stock-based compensation | $76.63M | $99.03M | $104.82M | $120.23M | -22.6% |
| Change in working capital | -$56.44M | $2.09M | -$21.94M | -$20.29M | -2,795.5% |
| Operating cash flow | $167.90M | $183.89M | $138.29M | $146.78M | -8.7% |
| Capital expenditure | -$74.02M | -$70.35M | -$55.77M | -$55.21M | -5.2% |
| Investing cash flow | -$119.96M | -$70.35M | -$55.77M | -$210.50M | -70.5% |
| Share buybacks | -$216.37M | -$158.84M | -$103.97M | -$101.72M | -36.2% |
| Financing cash flow | -$234.47M | -$337.50M | -$167.40M | -$120.23M | +30.5% |
| Free cash flow | $93.88M | $113.55M | $82.53M | $91.57M | -17.3% |
| End cash position | $261.82M | $448.35M | $672.30M | $757.16M | -41.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $200.41M | $194.01M | $194.78M | $196.03M | $203.07M | +3.3% |
| Operating revenue | $196.53M | $190.31M | $190.62M | $191.39M | $198.51M | +3.3% |
| Cost of revenue | $21.00M | $20.16M | $17.46M | $13.42M | $13.35M | +4.2% |
| Gross profit | $179.41M | $173.85M | $177.32M | $182.61M | $189.72M | +3.2% |
| Research & development | $26.71M | $30.18M | $28.94M | $31.01M | $29.93M | -11.5% |
| Selling, general & admin | $106.80M | $107.87M | $102.55M | $115.55M | $113.25M | -1.0% |
| Total operating expense | $155.78M | $159.84M | $154.64M | $167.99M | $162.91M | -2.5% |
| Operating income | $23.63M | $14.01M | $22.68M | $14.62M | $26.81M | +68.7% |
| Net interest income | -$8.79M | -$8.37M | -$8.51M | -$8.52M | -$7.93M | -5.0% |
| Pre-tax income | $15.47M | $5.64M | $14.19M | $6.10M | $19.58M | +174.3% |
| Tax provision | $6.93M | $4.47M | $8.77M | $4.98M | $6.73M | +55.0% |
| Net income | $8.54M | $1.17M | $5.42M | $1.12M | $12.84M | +630.2% |
| Net income to common | $8.54M | $1.17M | $5.42M | $1.12M | $12.84M | +630.2% |
| Basic EPS | 0.03 | 0.00 | 0.02 | 0.00 | 0.04 | — |
| Diluted EPS | 0.03 | 0.00 | 0.02 | 0.00 | 0.04 | — |
| EBIT | $25.28M | $15.41M | $24.60M | $16.93M | $30.31M | +64.1% |
| EBITDA | $47.55M | $37.20M | $47.74M | $38.36M | $50.03M | +27.8% |
| Basic shares | 339.28M | 340.53M | 340.20M | 346.78M | 356.62M | -0.4% |
| Diluted shares | 348.06M | 341.42M | 340.76M | 347.81M | 357.16M | +1.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $296.11M | $235.71M | $261.82M | $273.53M | $281.32M | +25.6% |
| Cash & short-term investments | $296.11M | $235.71M | $261.82M | $273.53M | $281.32M | +25.6% |
| Accounts receivable | $182.14M | $232.72M | $235.75M | $203.74M | $189.03M | -21.7% |
| Total current assets | $1.60B | $1.27B | $643.10M | $565.51M | $550.61M | +26.3% |
| Property, plant & equipment | $39.14M | $40.49M | $41.08M | $40.97M | $41.42M | -3.3% |
| Goodwill & intangibles | $628.88M | $631.69M | $633.67M | $626.61M | $625.57M | -0.4% |
| Total assets | $2.34B | $2.02B | $1.40B | $1.33B | $1.32B | +15.9% |
| Total current liabilities | $1.16B | $859.20M | $246.00M | $181.86M | $130.91M | +34.8% |
| Current debt | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | 0.0% |
| Long-term debt | $481.59M | $482.42M | $483.26M | $484.11M | $484.97M | -0.2% |
| Total debt | $538.95M | $541.35M | $542.81M | $545.13M | $547.54M | -0.4% |
| Total liabilities | $1.70B | $1.40B | $787.80M | $724.79M | $675.67M | +21.2% |
| Retained earnings | -$1.40B | -$1.41B | -$1.41B | -$1.42B | -$1.42B | +0.6% |
| Shareholder equity | $647.60M | $621.99M | $616.26M | $600.71M | $643.03M | +4.1% |
| Working capital | $441.46M | $407.27M | $397.10M | $383.66M | $419.70M | +8.4% |
| Net tangible assets | $18.72M | -$9.70M | -$17.41M | -$25.90M | $17.46M | +292.9% |
| Shares issued | 340.13M | 337.58M | 341.05M | 341.17M | 352.77M | +0.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $8.54M | $1.17M | $5.42M | $1.12M | $12.84M | +630.2% |
| Depreciation & amortisation | $22.27M | $21.79M | $23.15M | $21.43M | $19.73M | +2.2% |
| Stock-based compensation | $16.59M | $16.51M | $17.92M | $18.12M | $21.41M | +0.5% |
| Change in working capital | $26.00M | -$33.89M | -$28.32M | $25.80M | -$6.00M | +176.7% |
| Operating cash flow | $80.83M | $11.84M | $32.89M | $76.02M | $49.58M | +582.8% |
| Capital expenditure | -$14.41M | -$21.64M | -$15.83M | -$18.00M | -$18.32M | +33.4% |
| Investing cash flow | -$14.41M | -$21.64M | -$31.77M | -$18.00M | -$18.32M | +33.4% |
| Share buybacks | -$1.95M | -$12.57M | -$9.43M | -$61.05M | -$45.99M | +84.5% |
| Financing cash flow | -$6.02M | -$16.30M | -$12.83M | -$65.81M | -$50.93M | +63.1% |
| Free cash flow | $66.42M | -$9.81M | $17.06M | $58.02M | $31.27M | +777.4% |
| End cash position | $296.11M | $235.71M | $261.82M | $273.53M | $281.32M | +25.6% |
Options analytics
Put / call volume
2.42
Put-heavy session
Put / call open interest
0.20
Positioning, not flow
Max pain
2.50
-23.5% from spot
ATM implied vol
176.6%
Nearest strike to spot
Skew (10% OTM)
-54.7%
Calls bid over puts
Call volume
33
Contracts, this expiry
Put volume
80
Contracts, this expiry
Heaviest call OI
5.00
2.39K contracts
Heaviest put OI
2.50
255 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.08 | 0.08 | +0.4% |
| Mar 2026 | 0.07 | 0.07 | -2.2% |
| Dec 2025 | 0.09 | 0.09 | -1.7% |
| Sep 2025 | 0.09 | 0.08 | -12.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.08 | 11 | $202.13M | +3.1% |
| Next quarter | 0.08 | 11 | $201.83M | +3.6% |
| Current year | 0.30 | 11 | $798.28M | +0.2% |
| Next year | 0.35 | 11 | $838.66M | +5.1% |
Analyst targets & ownership
Mean target$3.95
High target$5.00
Low target$2.65
Implied upside21.17%
Analyst count12
ConsensusHOLD
Strong buy / Buy1 / 3
Hold8
Sell / Strong sell0 / 2
Held by insiders12.71%
Held by institutions55.85%
Institutions holding210
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.30
-1.33% from price
SMA 20
3.36
-2.64% from price
SMA 50
3.44
-4.87% from price
SMA 100
3.13
+4.19% from price
SMA 200
2.76
+18.57% from price
EMA 12
3.32
-1.92% from price
EMA 26
3.36
-3.07% from price
EMA 50
3.33
-2.04% from price
RSI (14)
44.0
Neutral
MACD (12,26,9)
-0.04
Hist -0.01
ATR (14)
0.10
3.05% of price
Realised vol 30D
36.3%
Annualised
Bollinger upper
3.51
20, 2σ
Bollinger lower
3.21
20, 2σ
50 / 200 cross
Golden
3.44 vs 2.76
Trend bias
Above 200
+18.57%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.33
More volatile than market
Correlation to SPY
0.31
Loosely linked
Realised vol 30D
36.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-59.7%
Peak to trough
Max drawdown 5Y
-96.0%
Peak to trough
ATR 14
0.10
3.05% of price
Beta (reported)
1.69
5Y monthly, from filing
Short interest
Shares short
4.73M
Prior 5.09M
Change vs prior
-7.2%
Shorts covering
% of float
4.93%
Normal
% of shares out
1.39%
Against total outstanding
Days to cover
3.3
Liquid
Float
93.97M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Aug 13, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Aug 11, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 11, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| May 14, 26 | Citigroup | MAINTAINED | Buy | Buy |
| May 11, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Mar 4, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Mar 3, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Mar 2, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Feb 27, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Feb 27, 26 | JP Morgan | DOWNGRADE | Overweight | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-18
Periodic Financial Reports
10-Q · 2026-05-06
Annual Report to Shareholders
ARS · 2026-04-29
Corporate Changes & Voting Matters
8-K · 2026-04-24
Corporate Changes & Voting Matters
8-K · 2026-04-03
Corporate Changes & Voting Matters
8-K · 2026-03-27
Corporate Changes & Voting Matters
8-K · 2026-03-18
Headlines
3 Cash-Producing Stocks We Steer Clear Of
StockStory · 14h ago
3 Reasons to Avoid GDRX and 1 Stock to Buy Instead
StockStory · 1d ago
Amazon (AMZN) and GoodRx (GDRX) Chase Prescription Subscribers as Insurance Coverage Slips
Insider Monkey · 5d ago
1 Value Stock to Target This Week and 2 That Underwhelm
StockStory · 8d ago
3 of Wall Street’s Favorite Stocks We Approach with Caution
StockStory · 22d ago
From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household
Business Wire · 34d ago
1 Momentum Stock with Exciting Potential and 2 That Underwhelm
StockStory · 36d ago
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)
StockStory · 53d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.